Fairmount Funds Management Llc's Net Worth
Fairmount Funds Management Llc's net worth is estimated to be at least $40,788,244.55 as of 05/02/2024. CoreStreet's estimation of Fairmount Funds Management Llc's net worth is based on their sale of stock and current holding of stock.
Fairmount Funds Management Llc is Director at Viridian Therapeutics Inc. They have executed at least 8 trades of stock as per SEC Form 4 filings. Their most recent trade was for 476,190 units of VRDN stock on 01/22/2024. Their biggest sale was on when they sold units of stock for $. They typically trade 2 times per year.
Total value of insider buys:
- $40,788,244.55
Total value of insider sells:
- $0.00
Most recent insider trade:
- Jan. 22, 2024
Fairmount Funds Management Llc's Insider Trading History
| Viridian Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Jan. 22, 2024 | Director | 476,190 | $21.00 | Buy | $9,999,990.00 |
Aug. 17, 2022 | Director | 425,531 | $23.50 | Buy | $9,999,978.50 |
| DNTH | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Sept. 29, 2023 | Director | 24,670 | $13.63 | Buy | $336,252.10 |
Sept. 26, 2023 | Director | 30,000 | $13.15 | Buy | $394,500.00 |
Sept. 19, 2023 | Director | 30,000 | $13.20 | Buy | $396,000.00 |
Sept. 12, 2023 | Director | 14,887 | $10.85 | Buy | $161,523.95 |
| Cogent Biosciences Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
June 9, 2023 | Major Shareholder | 800,000 | $12.00 | Buy | $9,600,000.00 |
June 16, 2022 | Major Shareholder | 1,200,000 | $8.25 | Buy | $9,900,000.00 |